Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Malone

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
Neoplasia (New York, N.Y.)|August 10, 2023
Altered endosomal-lysosomal biogenesis in melanomaGiang T Lam, Alexandra Sorvina, Carmela Martini, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
Neoplasia (New York, N.Y.)|August 10, 2023
Altered endosomal-lysosomal biogenesis in melanomaGiang T Lam, Alexandra Sorvina, Carmela Martini, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Pageof 2